Articles

Find an Article

Filter articles

Applied Filters

Showing 1 to 10 of 140 results

South Africa: Hope for measures to prevent abuse of the patent system

Africa, China, India09-05-2023Tyron Grant

Government-led schemes to incentivise patents are leading to delays and prejudice against legitimate applicants. Tyron Grant of Spoor and Fisher explains how South Africa is tackling the problem.

Pfizer’s pregabalin litigation: the latest twist

UK15-02-2023Darren Smyth

The long-running legal saga between the pharma giant and the NHS as well as generic drug makers has developed further, as Darren Smyth of EIP explains.

Why Novartis lost its treatment dispute with Teva

EU17-01-2023Azadeh Vahdat

The pharma company’s arguments focusing on ‘inventive step’ failed to convince a London court that the Israeli generic drug maker had infringed, explains Azadeh Vahdat of EIP.

Navigating the murky waters of the Hatch-Waxman ‘safe harbour’

US25-08-2022Jeanna Wacker and Tasha Francis Gerasimow

Safe harbour provisions can be relied on but their boundaries are still being defined, explain Jeanna Wacker and Tasha Francis Gerasimow of Kirkland & Ellis.

Why the ‘first penguin’ of pay for delay has not come in Japan: anatomy of a Japan paradox

Japan27-05-2022Takanori Abe

Why does Japan have no reverse payments culture? Takanori Abe of Abe & Partners unpicks a complex issue.

Neurim, Flynn discover that time is not on their side

UK26-05-2022Lydia Birch

The case reinforced the need for interim injunction applications to be made as quickly as possible, explains Lydia Birch of EIP.

South Africa: homeopathy case clarifies ‘medicine’ definition

South Africa23-05-2022Kareema Shaik and Jenny Pienaar

South Africa’s Supreme Court has declared regulations on complementary medicines invalid, explain Kareema Shaik and Jenny Pienaar of Adams & Adams.

When alliances fail, is arbitration the answer?

24-02-2022

The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy

NHS v Servier: unlawful means tort claim fails, but the long-running saga continues

UK17-08-2021Beatriz San Martin and Shishu Chen

The latest episode in the long-running dispute between the NHS and French pharmaceutical company Servier has been marked by a UK Supreme Court judgment of July 2, 2021 on Servier’s application to strike out the NHS’s unlawful means tort claim.

A new drug pricing system reform proposal in Japan

Japan17-08-2021Takanori Abe

A Japanese think tank is recommending an overhaul of Japan’s drug pricing system. Takanori Abe of Abe and Partners reports.

Showing 1 to 10 of 140 results

LSIPR